Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      One-Third of US Cancer Survivors Report Financial or Work-Related Hardship

      October 21, 2014
      By Andrew J. Roth
      Article
      Conferences|Palliative Care In Oncology Symposium

      Approximately one-third of cancer survivors in the US reported a financial problem or the need to modify work plans.

      Approximately one-third of cancer survivors in the US reported a financial problem or the need to modify work plans, according to the results of a large survey presented at the 2014 Palliative Care in Oncology Symposium. Women, racial/ethnic minorities, younger survivors, and uninsured survivors were all disproportionally affected by these hardships.

      The survey of 1592 survivors showed that 27% reported at least one financial problem, while 37% reported a work-related hardship.

      Cancer-related financial hardships included incurring debt, filing for bankruptcy, borrowing money, making sacrifices, and worrying about paying medical bills. Work hardships included changing to a flexible schedule or less demanding job, extending or taking unpaid leave, not accepting a promotion, delaying retirement, and taking an early retirement.

      “Cancer survivors are at increased risk of financial hardship,” Robin Whitney, RN, BSN, lead study author, cancer survivor, and PhD student at the Betty Irene Moore School of Nursing, University of California, Davis, said at a presscast held in advance of the symposium. “This is important not only because it can affect their quality of life, but also because individuals with more financial stress are more likely to delay or forgo needed medical care, which can put their health at risk.”

      This analysis focused on a subset of cancer survivors surveyed in the 2011 Medical Expenditures Panel Survey Experiences with Cancer Survivorship Supplement.

      Predictors of financial burden included active treatment, age, insurance status, health, and race/ethnicity. Patients undergoing active treatment experienced 92% more difficulties (odds ratio [OR] 3.2; 95% CI, 2.1-5.0), patients under age 65 experienced 130% more difficulties (OR 2.4; 95% CI, 1.7-3.3), and patients without insurance experienced 67% more difficulties (OR 2.4; 95% CI, 1.3-4.4). Minorities were also disproportionally affected: nonwhite patients experienced 41% more difficulties (OR 1.6; 95% CI, 1.1-2.3) than their white counterparts.

      Female patients experienced 30% more work modifications (OR 1.5; 95%, CI 1.1-2.2) than their male counterparts, though the difference was not statistically significant. Nonwhite patients experience 54% more modifications (OR 1.7; 95% CI, 1.1-2.6) that their white counterparts, whereas patients undergoing active treatment experienced 40% more work modifications than those who were at least 5 years removed from treatment (OR 2.9; 95% CI 1.7-4.9). Patients with worse health were also more likely to make a work modification, Whitney noted in the presscast.

      “Screening and support for these issues may be an important part of cancer care, not only during active treatment, but across the entire survivorship trajectory,” Whitney said. “Additional interventions might benefit groups who are at higher risk of having these problems, such as minorities, younger survivors, women, those without insurance, and those with worse overall health.”

      This analysis was the first to examine financial hardship disparities in a nationally representative group of cancer survivors, the authors noted. Overall, 47% of survivors surveyed were younger than age 65, 56% were female, 88% were white, and 4% did not have health insurance. Regarding treatment status, 14% were in active treatment, 46% were less than 5 years removed from treatment, and 39% were at least 5 years post treatment.

      As there are currently 12 million cancer survivors and over 18 million projected survivors by 2020, Jyoti D. Patel, MD, highlighted the need for new strategies to combat financial and work-related hardships. Patel is ASCO’s expert on the Symposium News Planning Team.

      “As we deal with the consequences of treatment and therapy, we need to find creative ways to lessen some of these hardships,” Patel said.

      Whitney RL, Bell J, Reed S, et al. Work and financial disparities among adult cancer survivors in the United States. Presented at: 2014 Palliative Care in Oncology Symposium; October 24-25, 2014; Boston, MA. Abstract 238.

      <<< View more from the Palliative Care in Oncology Symposium

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
      Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
      Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
      Image of a woman with white hair in front of an Oncology Nursing News blue background
      Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
      Man in suit standing in front of blue watercolor Oncology Nursing News backdrop
      Image of a woman in front of a blue Oncology Nursing News-branded backdrop.
      Man standing in front of Oncology Nursing News-branded backdrop
      a man wearing a suit and tie in front of a green screen with the ONN logo
      Related Content

      Image of red blood cells

      Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

      Ashling Wahner
      April 22nd 2025
      Article

      Lindsay Diamond Discusses Ongoing Role of Immunotherapy in Bladder Cancer

      Lindsay Diamond Discusses Ongoing Role of Immunotherapy in Bladder Cancer

      Lindsay Fischer
      April 3rd 2023
      Podcast

      Lindsay Diamond, MSN, AGNP-C, AOCNP, discusses findings from CheckMate 274 and other data presented during the 2023 ASCO Genitourinary Cancers Symposium.


      Image of blood with leukemia cells present

      Variability Found in PROs, Gene Expression During AML Induction Chemo

      Chris Ryan
      April 21st 2025
      Article

      Gene expression in peripheral blood as well as patient-reported outcomes differed for those with acute myeloid leukemia undergoing induction chemotherapy.


      The Vitals

      Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

      Lindsay Fischer
      March 1st 2023
      Podcast

      In this episode of "The Vitals," Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC, underscores potentially practice-changing data which were presented during the 2023 GI Cancers Symposium.


      Image of red blood cells

      Daratumumab Decreased Progression Risk in High-Risk Smoldering MM

      Jax DiEugenio
      April 19th 2025
      Article

      Daratumumab showed a decrease in disease progression or death risk vs active monitoring in patients with high-risk smoldering multiple myeloma.


      Image of patients of different ages in a waiting room

      Risk Factors Determine Symptom Burden Profiles by Age Group

      Bridget Hoyt
      April 18th 2025
      Article

      Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with cancer.

      Related Content

      Image of red blood cells

      Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

      Ashling Wahner
      April 22nd 2025
      Article

      Lindsay Diamond Discusses Ongoing Role of Immunotherapy in Bladder Cancer

      Lindsay Diamond Discusses Ongoing Role of Immunotherapy in Bladder Cancer

      Lindsay Fischer
      April 3rd 2023
      Podcast

      Lindsay Diamond, MSN, AGNP-C, AOCNP, discusses findings from CheckMate 274 and other data presented during the 2023 ASCO Genitourinary Cancers Symposium.


      Image of blood with leukemia cells present

      Variability Found in PROs, Gene Expression During AML Induction Chemo

      Chris Ryan
      April 21st 2025
      Article

      Gene expression in peripheral blood as well as patient-reported outcomes differed for those with acute myeloid leukemia undergoing induction chemotherapy.


      The Vitals

      Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

      Lindsay Fischer
      March 1st 2023
      Podcast

      In this episode of "The Vitals," Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC, underscores potentially practice-changing data which were presented during the 2023 GI Cancers Symposium.


      Image of red blood cells

      Daratumumab Decreased Progression Risk in High-Risk Smoldering MM

      Jax DiEugenio
      April 19th 2025
      Article

      Daratumumab showed a decrease in disease progression or death risk vs active monitoring in patients with high-risk smoldering multiple myeloma.


      Image of patients of different ages in a waiting room

      Risk Factors Determine Symptom Burden Profiles by Age Group

      Bridget Hoyt
      April 18th 2025
      Article

      Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with cancer.

      Latest Conference Coverage

      Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

      Acupuncture Use in BC Predicted by Social Determinants of Health

      Variability Found in PROs, Gene Expression During AML Induction Chemo

      Blinatumomab-Linked ICANS Cases Higher Than Previously Reported

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.